Hartford (Conn.) HealthCare is the first healthcare system in the state to utilize Caesarea, Israel-based Mazor Robotics’ Mazor X for spine surgeries.
Dublin, Ireland-based Medtronic announced the pricing of $2 billion-worth of senior notes.
Cambridge, Mass.-based InVivo Therapeutics announced the newest patient enrollee into its Inspire Study at Camden, N.J.-based Cooper Neurological Institute.
Zimmer Biomet led the $6.5 billion global hip replacement implant market in 2015.
Dublin, Ireland-based Mainstay Medical reported its full-year 2016 results, with its operating expenses totaling $16.8 million.
Caesarea, Israel-based Mazor Robotics is co-marketing and promoting its Mazor X technology with Medtronic.
Richard H. Bundschu, MD, of Bradenton, Fla.-based Coastal Orthopedics Sports Medicine & Pain Management, is a principal investigator for Nevro’s spinal cord stimulator study.
Houston-based Spine Injury Solutions, also known as SPIN, opened a Lubbock, Texas location as part of its affiliate expansion program.
Menlo Park, Calif.-based Asterias Biotherapeutics announced the sixth and final patient was administered AST-OPC1 after complete paralysis, and has exhibited positive signs following the six-month study.
Maple Grove, Minn.-based CVRx President and CEO Namid Yared was named chairman of Washington, D.C.-based AdvaMed’s board of directors.
More articles on devices:
Orthopedic, neurosurgery & cardiac fields spurring global medical robots market: 4 insights
Spine Injury Solutions expands — 5 things to know
Invivo announces 13th Inspire Study enrollee — 4 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
